Javier De Castro, MD

Articles by Javier De Castro, MD

The UFT/Leucovorin/Etoposide Regimen for the Treatment of Advanced Gastric Cancer

ByManuel González Barón, MD,Enrique Espinosa, MD,Jaime Feliu, MD,Amalio Ordóñez, MD,Pilar Zamora, MD,Javier De Castro, MD,Carlos García Girón, MD,Pilar García Alfonso, MD,Pilar Garrido, MD,Joaquin Belón, MD,Maria Lomas, MD

September 2nd 1997

Gastric cancer is the most chemosensitive adenocarcinoma among digestive neoplasms. A few years ago, we performed a phase II trial with the FLEP regimen, in which fluorouracil (5-FU) and leucovorin are combined

Latest Updated Articles

The UFT/Leucovorin/Etoposide Regimen for the Treatment of Advanced Gastric Cancer
Published: September 2nd 1997 | Updated:

Javier De Castro, MD

Articles by Javier De Castro, MD

The UFT/Leucovorin/Etoposide Regimen for the Treatment of Advanced Gastric Cancer

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma

FDA Grants Fast Track Designation to MT-125 in Glioblastoma

HDP-101 Receives FDA Fast Track Designation in Multiple Myeloma

FDA Accepts NDA for New Nilotinib Formulation in CML

Collagen Implant May Improve Local Control of Metastatic Brain Tumors